Natasha Leigh1, Gregory A Williams2, Steven M Strasberg2, Ryan C Fields2, William G Hawkins2, Chet W Hammill2, Dominic E Sanford2. 1. Department of Surgery, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. tashleigh88@gmail.com. 2. Department of Surgery, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Abstract
BACKGROUND: Frailty is associated with postoperative mortality, but its significance after hepatectomy for colorectal liver metastases (CRLM) is poorly defined. This study evaluated the impact of frailty after hepatectomy for CRLM. METHODS: The study identified 8477 patients in National Surgical Quality Improvement Program databases from 2014 to 2019 and stratified them by frailty score using the risk analysis index as very frail (>90th percentile), frail (75th-90th percentile), or non-frail (< 75th percentile). Multivariate regression models determined the impact of frailty on perioperative outcomes, including by the extent of hepatectomy. RESULTS: The procedures performed were 2752 major hepatectomies (left hepatectomy, right hepatectomy, trisectionectomy) and 5725 minor hepatectomies (≤2 segments) for 870 (10.3%) very frail, 1680 (19.8%) frail, and 5927 (69.9%) non-frail patients. Postoperatively, the very frail and frail patients experienced more complications (very frail [41.8%], frail [35.1%], non-frail [31.0%]), which resulted in a longer hospital stay (very-frail [5.7 days], frail [5.8 days], non-frail [5.1 days]), a higher 30-day mortality (very-frail [2.2%], frail [1.3%], non-frail [0.5%]), and more discharges to a facility (very frail [6.8%], frail [3.7%], non-frail [2.6%]) (p < 0.05) although they underwent similarly extensive (major vs. minor) hepatectomies. In the multivariate analysis, frailty was independently associated with complications (very-frail [odds ratio {OR}, 1.70], frail [OR, 1.25]) and 30-day mortality (very-frail [OR, 4.24], frail [OR, 2.41]) (p < 0.05). After minor hepatectomy, the very frail and frail patients had significantly higher rates of complications and 30-day mortality than the non-frail patients, and in the multivariate analysis, frailty was independently associated with complications (very frail [OR, 1.97], frail [OR, 1.27]) and 30-day mortality (very frail [OR, 6.76], frail [OR, 3.47]) (p < 0.05) after minor hepatectomy. CONCLUSIONS: Frailty predicted significantly poorer outcomes after hepatectomy for CRLM, even after only a minor hepatectomy.
BACKGROUND: Frailty is associated with postoperative mortality, but its significance after hepatectomy for colorectal liver metastases (CRLM) is poorly defined. This study evaluated the impact of frailty after hepatectomy for CRLM. METHODS: The study identified 8477 patients in National Surgical Quality Improvement Program databases from 2014 to 2019 and stratified them by frailty score using the risk analysis index as very frail (>90th percentile), frail (75th-90th percentile), or non-frail (< 75th percentile). Multivariate regression models determined the impact of frailty on perioperative outcomes, including by the extent of hepatectomy. RESULTS: The procedures performed were 2752 major hepatectomies (left hepatectomy, right hepatectomy, trisectionectomy) and 5725 minor hepatectomies (≤2 segments) for 870 (10.3%) very frail, 1680 (19.8%) frail, and 5927 (69.9%) non-frail patients. Postoperatively, the very frail and frail patients experienced more complications (very frail [41.8%], frail [35.1%], non-frail [31.0%]), which resulted in a longer hospital stay (very-frail [5.7 days], frail [5.8 days], non-frail [5.1 days]), a higher 30-day mortality (very-frail [2.2%], frail [1.3%], non-frail [0.5%]), and more discharges to a facility (very frail [6.8%], frail [3.7%], non-frail [2.6%]) (p < 0.05) although they underwent similarly extensive (major vs. minor) hepatectomies. In the multivariate analysis, frailty was independently associated with complications (very-frail [odds ratio {OR}, 1.70], frail [OR, 1.25]) and 30-day mortality (very-frail [OR, 4.24], frail [OR, 2.41]) (p < 0.05). After minor hepatectomy, the very frail and frail patients had significantly higher rates of complications and 30-day mortality than the non-frail patients, and in the multivariate analysis, frailty was independently associated with complications (very frail [OR, 1.97], frail [OR, 1.27]) and 30-day mortality (very frail [OR, 6.76], frail [OR, 3.47]) (p < 0.05) after minor hepatectomy. CONCLUSIONS: Frailty predicted significantly poorer outcomes after hepatectomy for CRLM, even after only a minor hepatectomy.
Authors: Shelley A Sternberg; Andrea Wershof Schwartz; Sathya Karunananthan; Howard Bergman; A Mark Clarfield Journal: J Am Geriatr Soc Date: 2011-09-21 Impact factor: 5.562
Authors: Daniel E Hall; Shipra Arya; Kendra K Schmid; Mark A Carlson; Pierre Lavedan; Travis L Bailey; Georgia Purviance; Tammy Bockman; Thomas G Lynch; Jason M Johanning Journal: JAMA Surg Date: 2017-03-01 Impact factor: 14.766
Authors: Myrick C Shinall; Shipra Arya; Ada Youk; Patrick Varley; Rupen Shah; Nader N Massarweh; Paula K Shireman; Jason M Johanning; Alaina J Brown; Neil A Christie; Lawrence Crist; Catherine M Curtin; Brian C Drolet; Rajeev Dhupar; Jennifer Griffin; James W Ibinson; Jonas T Johnson; Sonja Kinney; Chad LaGrange; Alexander Langerman; Gary E Loyd; Leila J Mady; Michael P Mott; Murali Patri; Justin C Siebler; C J Stimson; William E Thorell; Scott A Vincent; Daniel E Hall Journal: JAMA Surg Date: 2020-01-15 Impact factor: 14.766
Authors: Rupen Shah; Kristopher Attwood; Shipra Arya; Daniel E Hall; Jason M Johanning; Emmanuel Gabriel; Anthony Visioni; Steven Nurkin; Moshim Kukar; Steven Hochwald; Nader N Massarweh Journal: JAMA Surg Date: 2018-05-16 Impact factor: 14.766
Authors: Shipra Arya; Patrick Varley; Ada Youk; Jeffrey D Borrebach; Sebastian Perez; Nader N Massarweh; Jason M Johanning; Daniel E Hall Journal: Ann Surg Date: 2020-12 Impact factor: 12.969